Seward simplifies cell preparation
Enhances applications for Strainer bags to include sterile processing of tissue samples
Gamma irradiated sterile and available in a range of sizes, the Strainer bags are compatible with all laboratory paddle blenders, including Seward’s Stomacher 80 Biomaster series. Because they are fully containable and easily used in a sterile environment, the Strainer bags can be used for new applications in cell culture.
The 0.5mm pore size of the integrated strainer element within the Seward Strainer bag generates a uniformly homogenous cell suspension, says the Worthing-based company. This allows the cells’ passage through the pores of the central straining matrix and prevents contamination with undigested extracellular material, which can block pipettes. Produced to provide a sterile, secure environment for the preparation of single cell suspensions, the Strainer bag is suitable for the individual processing of a large number of samples.
“The new life-science applications of our robust Strainer bag technology represent the continuing, customer oriented, development to which Seward is committed,” said Stuart Ray, technical director at Seward Ltd.
“Cell scientists can simplify their primary culture preparations by straining the processed tissues to ensure trouble-free pipetting, whilst also increasing the viability of the cells produced as the end product.”
You may also like
Trending Articles
You may also like
Manufacturing
Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system
Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing
Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering